The rationale and design of the Micra Transcatheter Pacing Study: Safety and efficacy of a novel miniaturized pacemaker

Europace

Volumn 17, Issue 5, 2015, Pages 807-813

  Ritter, Philippe ^a   Duray, Gabor Z ^b   Zhang, Shu ^c   Narasimhan, Calambur ^d   Soejima, Kyoko ^e   Omar, Razali ^f   Laager, Verla ^g   Stromberg, Kurt ^g   Williams, Eric ^g   Reynolds, Dwight ^h  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Medical Centre   (Hungary)

^c FUWAI HOSPITAL   (China)

^d CARE Foundation   (India)

^e KYORIN UNIVERSITY   (Japan)

^f NATIONAL HEART INSTITUTE   (Malaysia)

^g MEDTRONIC   (United States)

^h UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Delivery catheter; Leadless pacemaker; Miniaturization; Pacemaker; Transcatheter pacing system

Indexed keywords

ADULT; ARTICLE; ATRIAL FIBRILLATION; DEVICE SAFETY; FOLLOW UP; HEART PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE CHAMBER PACEMAKER; ADVERSE EFFECTS; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; CLINICAL PROTOCOL; CLINICAL TRIAL; ELECTRONICS; EQUIPMENT DESIGN; METHODOLOGY; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; CLINICAL PROTOCOLS; EQUIPMENT DESIGN; HUMANS; MINIATURIZATION; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929235090     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv026     Document Type: Article

References (20)

1. Mallela VS, Ilankumaran V, Rao NS. Trends in cardiac pacemaker batteries. Indian Pacing Electrophysiol J 2004;4:201-12.
2. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusef A, GillisAM et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.NEngl J Med 2000; 342:1385-91.
3. Johansen JB, Jrgensen OD, MllerM, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-8.
4. Bonner MD, Eggen M, Hilpisch K, Sheldon TJ, Williams E. Performance of the Medtronic Micra Transcatheter Pacemaker in a GLP study. Heart Rhythm 2014;11: S19.
5. Eggen MD, Bonner MD,Sheldon TJ, Williams ER, Iaizzo PA. Implantation of a leadless pacemaker within reanimated human hearts using direct visualization. Presented at HRS 2013 (PO03-08).
6. Bonner M, Eggen M, Depalo J, Sheldon T, Williams E. Assessment of leadless pacemaker performance. Eur Heart J 2013;34: doi:10.1093/eurheartj/eht308.1918.
7. Coates S, Thwaites B. The strength-duration curve and its importance in pacing efficiency: a study of 325 pacing leads in 229 patients. Pacing Clin Electrophysiol 2000;23: 1273-7.
8. Gammage MD, Lieberman RA, Yee R, Manolis AS, Compton SJ, Khazen C et al. Multi-center clinical experience with a lumenless, catheter-delivered, bipolar, permanent pacemaker lead: implant safety and electrical performance. Pacing Clin Electrophysiol 2006;29:858-65.
9. Medtronic, Inc. CapsureFix Novus 5076 Technical Manual. Medtronic, Inc., 2005.
10. Gillis AM, Pürerfellner H, IsraelCW, Sunthorn H, Kacet S, Anelli-MontiMet al. Medtronic Enrhythm Clinical Study Investigators. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin Electrophysiol 2006;29:697-705.
11. Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, Heuer H et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011;8:65-73.
12. Schwitter J, Kanal E, Schmitt M, Anselme F, Albert T, Hayes DL et al. Impact of the Advisa MRI pacing system on the diagnostic quality of cardiac MR images and contraction patterns of cardiac muscle during scans: Advisa MRIrandomized clinical multicenter study results. Heart Rhythm 2013;10:864-72.
13. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007; 357:1000-8.
14. Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014;35:1186-94.
15. Wilkoff BL, Corey J, Blackburn G.Amathematical model of the cardiac chronotropic response to exercise. J Electrophysiol 1989;3:176-80.
16. Hwang IK, Shih WJ, DeCani JS. Group sequential designs using a family of type I error probability spending functions. Stat Med 1990;9:1439-45.
17. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 2010;122:1553-61.
18. Spickler JW, Rasor NS, Kezdi P, Misa SN, Robins KE, LeBoeuf C. Totally selfcontained intracardiac pacemaker. J Electrocardiol 1970;3:325-31.
19. Bonner MD, Neafus N, Byrd CL, Schaerf RH, Goode L. Extraction of the Micra transcatheter pacemaker system. Heart Rhythm 2014;11:S342.
20. St. Jude Medical NanostimTM Leadless Pacemaker [Internet] 2014 Oct 2. http://professional-intl.sjm.com/professional/products/crm/leadless-pacemakers/dual-and-single-chamber/nanostim#overview.